Research - News
The grant, received from the NIH, aims to provide a better option for patients than what is already available.
An award to UAB researchers is aimed to determine effects of arsenicals and ways to treat exposure in the future.
The goal is an early warning system to block incipient seizures for patients where medications have failed.
An increased association with STI in a vaginitis screening population has been found by a UAB researcher.
This remarkable ability has clinical implications for humans.
The National Cancer Institute highlighted research from UAB that shows how the epigenetic plant-based diet in mice can prevent cancer more effectively at younger ages.
UAB research suggests protein misfolding, perhaps caused by a reduction in a regulatory protein, could be associated with Parkinson’s disease.
These newborn neurons in the dentate gyrus become less excitable after three weeks, a crucial step for mature functioning.
This discovery may lead to personalized care for congestive heart failure, also known as ischemic cardiomyopathy.
UAB's study of CBD oil for intractable epilepsy, funded by the State of Alabama under Carly's Law, shows that CBD oil reduces seizure frequency and severity in patients with treatment-resistant epilepsy.
UAB research points to a new way to lower pre-term births: teach mothers the fundamentals of oral health.
The drug targets enzymes that control the immune response and spleen macrophages.
Arts experiences may help hospitalized patients at risk of delirium.
Findings show that patients who received a blood or marrow transplant as a child may be at a higher risk of related death.
UAB is renewed for another five years in NeuroNEXT, a national clinical research program in brain disorders.
UAB was part of a groundbreaking trial that is believed to be the first time it has been proved that the risk of mild cognitive impairment and dementia can be reduced through high blood-pressure treatment.
Researchers found that prolonged oxygen supplementation adversely affected the development of memory function in preterm infants.
Two new studies will have an intriguing mix of catalysts, “tunable” chemical bonds, supercomputers and ultrafast lasers.
UAB in Antarctica has fruitful research season on Earth’s southernmost continent.
A gene mutation causes wrinkled skin and hair loss; turning off that mutation restores the mouse to normal appearance.
The mechanism the tuberculosis pathogen uses in its escape suggests possible therapies to improve patient outcomes.
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.
A gene called TXNIP was the answer, and it led to a drug called verapamil and a successful diabetes trial.
Biomedical scientists and engineers can participate in a nationwide program that helps take their discoveries from the research lab to the clinical setting.
A diabetes drug suggests potential therapy for idiopathic pulmonary fibrosis, based on research with human lung fibroblasts and a mouse model of lung fibrosis.
A UAB researcher hopes to use new data tools to find answers to a dangerous form of epilepsy.
UAB is one of six universities in the world currently investigating the medicinal benefits of psilocybin.
These immune cells could become therapeutic targets to treat Crohn’s disease and ulcerative colitis.
In a large-scale analysis, Jeremy Blackburn, Ph.D., and collaborators found that the misuse of web archive services cause loss of ad revenue for popular news websites.
Tensor completion algorithm proposed for use in making recommendations via Netflix and Amazon.